Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Feb 25;288(6417):585–586. doi: 10.1136/bmj.288.6417.585

Chemotherapy of solid tumours: trials and tribulations.

G M Mead, J M Whitehouse
PMCID: PMC1444341  PMID: 6421389

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis S., Kessler W. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol. 1979;3(1):57–59. doi: 10.1007/BF00254421. [DOI] [PubMed] [Google Scholar]
  2. Drelichman A., Cummings G., Al-Sarraf M. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck. Cancer. 1983 Aug 1;52(3):399–403. doi: 10.1002/1097-0142(19830801)52:3<399::aid-cncr2820520303>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Glick J. H., Taylor S. G., 4th Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):229–242. doi: 10.1016/0360-3016(81)90442-9. [DOI] [PubMed] [Google Scholar]
  4. Hong W. K., Schaefer S., Issell B., Cummings C., Luedke D., Bromer R., Fofonoff S., D'Aoust J., Shapshay S., Welch J. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer. 1983 Jul 15;52(2):206–210. doi: 10.1002/1097-0142(19830715)52:2<206::aid-cncr2820520204>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. Mead G. M., Jacobs C. Changing role of chemotherapy in treatment of head and neck cancer. Am J Med. 1982 Oct;73(4):582–595. doi: 10.1016/0002-9343(82)90339-4. [DOI] [PubMed] [Google Scholar]
  6. O'Connor D., Clifford P., Edwards W. G., Dalley V. M., Durden-Smith J., Hollis B. A., Calman F. M. Long-term results of VBM and radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1982 Sep;8(9):1525–1531. doi: 10.1016/0360-3016(82)90612-5. [DOI] [PubMed] [Google Scholar]
  7. Shapshay S. M., Hong W. K., Incze J. S., Yamaguchi K., Bhutani R., Vaughan C. W., Strong M. S. Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg. 1978 Oct;136(4):534–538. doi: 10.1016/0002-9610(78)90277-5. [DOI] [PubMed] [Google Scholar]
  8. Stell P. M., Dalby J. E., Strickland P., Fraser J. G., Bradley P. J., Flood L. M. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol. 1983 Jul;34(4):463–467. doi: 10.1016/s0009-9260(83)80247-5. [DOI] [PubMed] [Google Scholar]
  9. Tannock I., Murphy K. Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results. J Clin Oncol. 1983 Jan;1(1):66–70. doi: 10.1200/JCO.1983.1.1.66. [DOI] [PubMed] [Google Scholar]
  10. Tannock I., Sutherland D., Osoba D. Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer. Cancer. 1982 Apr 1;49(7):1358–1361. doi: 10.1002/1097-0142(19820401)49:7<1358::aid-cncr2820490709>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  11. Woods R. L., Fox R. M., Tattersall M. H. Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):600–602. doi: 10.1136/bmj.282.6264.600. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES